Clinical trial Recruiting at 1 site Observational Ages Any age to 20

Evaluation of patients with traumatic and hypoxic-ischemic brain injuries

Official title: Clinical and Epidemiological Evaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06873477 · Data updated 2026-11-12

This study is trying to understand how brain injuries from trauma or lack of oxygen affect kids and young adults under 20, to find better ways to help them.

More Brain Injuries trials

Quick facts

Study typeObservational
AgesAny age to 20 Years
SexAll
Enrollment50 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome, Lazio)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedJanuary 31, 2027
Study endsJuly 31, 2027
Registry record updatedMarch 12, 2025
Trial IDNCT06873477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 0-20 years with brain damage from severe traumatic brain injury or perinatal asphyxia.

Probably not a fit

Patients with congenital malformations, genetic syndromes, neuromuscular diseases, or encephalopathies from other causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients aged 0-20 years who have experienced brain damage due to severe traumatic brain injury or perinatal asphyxia. It aims to evaluate the neurological function disturbances associated with neonatal hypoxic-ischemic encephalopathy, a condition that can lead to significant long-term disabilities. The study will involve assessments at the Pediatric Emergency Department, where informed consent will be obtained from parents or legal guardians. The research seeks to better understand the complexities of brain injuries in this vulnerable population and explore potential new treatment avenues.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment options for infants and children suffering from severe brain injuries.

How similar studies have gone: While therapeutic hypothermia is currently the standard treatment, this study explores new approaches, indicating a need for further investigation in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 0-20 years with brain damage due to severe traumatic brain injury or perinatal asphyxia evaluated at the Pediatric Emergency Department
* Informed consent signed by the parents, the adult patient, or the legal guardian/representative.
* Adult patients with psycho-cognitive impairments that affect their ability to provide consent, with prior acquisition of informed consent from the guardian/legal representative.

Exclusion Criteria:

* Refusal to sign the informed consent
* Patients with congenital malformations or genetic syndromes
* Patients with neuromuscular diseases
* Patients with encephalopathies of etiology other than severe head trauma or asphyxia
* Patients with hemodynamically significant congenital heart diseases

Where it's running

  • Fondazione Policlinico Universitario A. Gemelli IRCCS, Pronto Soccorso Pediatrico
    Rome, Lazio, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.